Minimal Change Disease

(Lipoid Nephrosis; Nil Disease)

ByFrank O'Brien, MD, Washington University in St. Louis
Reviewed/Revised Jun 2023
View Patient Education

(See also Overview of Nephrotic Syndrome.)

Minimal change disease is the most common cause of nephrotic syndrome in children 4 to 8 years (80 to 90% of childhood nephrotic syndrome), but it also occurs in adults (10 to 20% of adult nephrotic syndrome). The cause is almost always unknown, although rare cases may occur secondary to drug use (especially nonsteroidal anti-inflammatory drugs [NSAIDs]) and hematologic cancers (especially Hodgkin lymphoma).

Symptoms and Signs of Minimal Change Disease

Minimal change disease causes nephrotic syndrome, usually without hypertension or azotemia; microscopic hematuria occurs in about 20% of patients, mainly adults. Azotemia can occur in secondary cases and in patients >

Diagnosis of Minimal Change Disease

  • In adults with idiopathic nephrotic syndrome, renal biopsy

In children, the diagnosis can be suspected (and treatment begun) based on the following typical characteristics:

  • Normal renal function

  • Non-nephritic urine sediment

Renal biopsy is required in adults and in children with atypical presentations. Electron microscopy demonstrates edema with diffuse swelling (effacement) of foot processes of the epithelial podocytes (see figure Electron microscopic features in immunologic glomerular disorders ). Complement and Ig deposits are absent on immunofluorescence. Although effacement is not observed in the absence of proteinuria, heavy proteinuria may occur with normal foot processes.

Electron microscopic features in immunologic glomerular disorders

Treatment of Minimal Change Disease

  • Corticosteroids

Corticosteroids

2

Treatment is usually continued for 1 to 2 years. However, half or more relapse, requiring treatment with the same or a different regimen.

Other immunosuppressive therapies

In corticosteroid nonresponders (< 5% of children and > 10% of adults), frequent relapsers, and corticosteroid-dependent patients, prolonged remission may be achieved with the addition of another immunosuppressive agent (1, 2

Treatment references

  1. 1. Larkins NG, Liu ID, Willis NS, et al: Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 4(4):CD002290, 2020. doi: 10.1002/14651858.CD002290.pub

  2. 2. Azukaitis K, Palmer SC, Strippoli GF, et al: Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev 3(3):CD001537, 2022. doi: 10.1002/14651858.CD001537.pub5

Prognosis for Minimal Change Disease

The prognosis for patients with minimal change disease who receive treatment is favorable, and > 80% of patients achieve remission. Progression to renal failure occurs in < 5 % of patients and is more common among those who do not initially respond to corticosteroids (1).

Prognosis reference

  1. 1. Tarshish P, Tobin JN, Bernstein J, et al: Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8(5):769-776, 1997 doi: 10.1681/ASN.V85769

Key Points

  • Minimal change disease accounts for most cases of nephrotic syndrome in children and is usually idiopathic.

  • Suspect minimal change disease in children who have sudden onset of nephrotic-range proteinuria with normal renal function and a non-nephritic urine sediment.

  • Confirm the diagnosis by renal biopsy in adults and atypical childhood cases.

  • Treat initially with corticosteroids.

  • The prognosis is favorable, and the majority of patients achieve remission with initial treatment.

quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
Download the free MSD Manual App iOS ANDROID
Download the free MSD Manual App iOS ANDROID
Download the free MSD Manual App iOS ANDROID